Humana (NYSE:HUM) Stock Price Up 0.1%

Shares of Humana Inc. (NYSE:HUM) rose 0.1% during trading on Monday . The company traded as high as $322.89 and last traded at $320.75. Approximately 336,794 shares changed hands during mid-day trading, a decline of 83% from the average daily volume of 1,972,597 shares. The stock had previously closed at $320.54.

Wall Street Analyst Weigh In

Several analysts recently issued reports on HUM shares. Argus downgraded Humana from a “buy” rating to a “hold” rating in a report on Wednesday, March 13th. Jefferies Financial Group decreased their target price on shares of Humana from $411.00 to $381.00 and set a “buy” rating for the company in a research report on Monday, April 22nd. Barclays cut their price target on Humana from $356.00 to $310.00 and set an “equal weight” rating on the stock in a report on Tuesday, April 2nd. Royal Bank of Canada lowered their target price on Humana from $415.00 to $353.00 and set an “outperform” rating on the stock in a research report on Thursday, April 25th. Finally, UBS Group lowered their price target on Humana from $334.00 to $326.00 and set a “neutral” rating on the stock in a report on Thursday, April 25th. Eleven research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $424.50.

Humana Trading Down 0.4 %

The stock has a market cap of $38.47 billion, a P/E ratio of 19.88, a price-to-earnings-growth ratio of 1.86 and a beta of 0.49. The company has a current ratio of 1.67, a quick ratio of 1.67 and a debt-to-equity ratio of 0.77. The business’s fifty day simple moving average is $323.55 and its 200 day simple moving average is $387.14.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, April 24th. The insurance provider reported $7.23 EPS for the quarter, beating the consensus estimate of $6.12 by $1.11. Humana had a net margin of 1.82% and a return on equity of 17.76%. The business had revenue of $29.61 billion for the quarter, compared to analysts’ expectations of $28.52 billion. During the same period in the prior year, the firm earned $9.38 earnings per share. Humana’s revenue was up 10.7% compared to the same quarter last year. As a group, analysts expect that Humana Inc. will post 16.18 EPS for the current year.

Humana Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, July 26th. Stockholders of record on Friday, June 28th will be paid a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a dividend yield of 1.11%. The ex-dividend date is Friday, June 28th. Humana’s dividend payout ratio (DPR) is presently 22.04%.

Insider Buying and Selling

In other Humana news, Director Jorge S. Mesquita purchased 545 shares of the company’s stock in a transaction that occurred on Tuesday, February 20th. The stock was acquired at an average cost of $367.09 per share, with a total value of $200,064.05. Following the completion of the purchase, the director now directly owns 2,578 shares in the company, valued at approximately $946,358.02. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 0.29% of the company’s stock.

Hedge Funds Weigh In On Humana

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Cambridge Investment Research Advisors Inc. lifted its holdings in Humana by 30.0% during the third quarter. Cambridge Investment Research Advisors Inc. now owns 9,196 shares of the insurance provider’s stock worth $4,474,000 after acquiring an additional 2,124 shares in the last quarter. Stratos Wealth Partners LTD. boosted its stake in Humana by 4.2% in the 3rd quarter. Stratos Wealth Partners LTD. now owns 1,294 shares of the insurance provider’s stock worth $630,000 after purchasing an additional 52 shares during the period. Independent Advisor Alliance increased its holdings in Humana by 5.1% during the 3rd quarter. Independent Advisor Alliance now owns 1,379 shares of the insurance provider’s stock worth $671,000 after purchasing an additional 67 shares in the last quarter. Brown Advisory Inc. lifted its holdings in shares of Humana by 17.3% in the third quarter. Brown Advisory Inc. now owns 2,311 shares of the insurance provider’s stock valued at $1,124,000 after purchasing an additional 341 shares in the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank boosted its position in shares of Humana by 10.2% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 44,643 shares of the insurance provider’s stock worth $21,720,000 after buying an additional 4,138 shares during the period. Institutional investors own 92.38% of the company’s stock.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.